Hypertension, Vol 6, 468-474, Copyright © 1984 by American Heart Association
KA Gruber, MC Klein, PM Hutchins, VM Buckalew Jr and JR Lymangrover
The hypertensive and natriuretic effects of chronic administration of
adrenocorticotrophic hormone (ACTH) cannot be duplicated by the
administration of glucocorticoids and/or mineralocorticoids. We
investigated the effects of a fragment of this hormone (ACTH4-10) and an
analog of the fragment (D-Phe7) ACTH4-10 and found them to have pressor and
cardioaccelerator actions in rats as determined by bolus intravenous (i.v.)
injections of 30 to 1000 nmol/kg. The pressor and cardioaccelerator effects
of (D-Phe7) ACTH4-10 were attenuated by alpha- receptor (phentolamine) and
beta-receptor (metoprolol) antagonists. The cardiovascular actions of
ACTH4-10 were produced in adrenalectomized or ganglionic-blocked (with
mecamylamine) rats. At a lower dose (7 nmol/kg i.v.), ACTH4-10 was
natriuretic and had a pattern of activity similar to that of a larger ACTH
fragment, alpha-melanocyte-stimulating hormone. Extraadrenal effects of the
intact ACTH molecule or the in vivo production of an ACTH4-10-like fragment
from ACTH may contribute to the hypertensive and natriuretic actions
associated with this hormone.
ARTICLES
Natriuretic and hypertensive activities reside in a fragment of ACTH
This article has been cited by other articles:
![]() |
P. Manning, D Schwartz, N. Katsube, S. Holmberg, and P Needleman Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis Science, July 26, 1985; 229(4711): 395 - 397. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |